Who Are We?

We were born from the deep discussion of our dynamic leaders in Starbucks. We were incorporated and registered with the Securities & Exchange Commission (SEC) on July 13, 2009. The company was established primarily to engage in trading goods such as medical supplies, equipment, pharmaceutical products, and food supplements on wholesale & retail basis.

The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital, Inc. Both entities are incorporated in the Philippines and DLX Holdings, Inc. is the company’s immediate and ultimate parent company.

At the moment, Delex Pharma International, Inc. provides the following solutions to our clients:

Sales and Marketing
Support for product registration and compliance
Sales Order Processing
Warehousing
Invoicing
Delivery and Transportation
Collection
Credit and Risk Management

Delex was established to market the hospital & critical care range of products with special focus in the intensive care setting of the hospitals, to include the Intensive Care Units, Emergency Rooms and Operating Theaters.

Our History

View More....

Our Humble beginning

View More.....

1st National Sales Conference
Estancia Resort Hotel, Tagaytay
March 2010

View More...

2nd National Sales Conference
Meralco Management and Leadership Development Center, Sumulong Highway, Antipolo
March 2011

View More...

3rd National Sales Conference
Estancia Resort Hotel, Tagaytay
March 2012

View More...

4th National Sales Conference
Meralco Management and Leadership Development Center, Sumulong Highway, Antipolo
March 2013

View More...

5th National Sales Conference
Tanza Oasis Hotel and Resort
Tanza, Cavite
March 2014

View More...

6th National Sales Conference
Tanza Oasis Hotel and Resort
Tanza, Cavite
March 2015

View More...

7th National Sales Conference
The Greenery Resort,
Baliuag, Bulacan
March 2016

Our Strategic Direction

Where are we going

We shall strive to rapidly grow our business to a position of market strength by achieving total revenues of P1 Billion in the next 5 years. We shall build a strong team whose members are committed to live out our Mission and Values, and shall be led by highly trained effective leaders. To enhance our competitiveness and flexibility, we shall improve our key business processes, embark on establishing our manufacturing facility, look into the possibility of expanding our presence in neighboring countries. Our aspirations will not be achieved without the business zeal of our people which will differentiate us from our competitors. We shall take care of our people by providing an environment that nurtures their growth and by looking after their needs with programs that are competitive with benchmark companies. We shall continue with our corporate social responsibility programs to benefit the less privileged in society.

We intend to aggressively expand our product line and customer base.  We want to tap the available sales and marketing opportunities and create new niches.  We can achieve this by being a key player both in the critical and general care markets.  We plan to serve the pediatric and adult intensive care units (ICUs), coronary care and oncology units, operating rooms (ORs), and emergency rooms (ERs).

We will bring pride to our country as we want to earn the trust and the confidence of our customers, principals, manufacturers, and suppliers from Asia, the US, Europe, and Latin America.

Our Management

Our core Leaders has high competence in the hospital product business, which spans from 13-30 years of solid experience. Top & Consistent Sales Performers. Strategists. Hard working.

Core competencies include:

  • Sales & Marketing excellence, Hospital negotiations, Salesforce effectiveness, Account Development Strategy, Training & Development and Customer Relationship.
  • A strong knowledge based on Critical Care Products, Emergency drugs, IV solutions, IV specialty Drugs, Critical Care Drugs, Anti-infectives, Medical Devices and Nutritional products.
Learn More...

2018 Delex Organizational Structure

Mr. J de Ruyter “Toto” Oroceo
President & General Manager


Ms. Ma. Lourdes Monasterio, VP for Sales & Marketing

Mr. Noel Omandam, VP for Operations

Mr. Chris Quilala, National Sales Manager

Ms. Ana Lyn Matienzo, Finance Manager

Ms. Allery Flores, Human Resources & Admin. Manager

Mr. Melandrino Diego, I.T. Manager

Ms. Puela Delapena, TSD National Sales Manager

Ms. Grace Du-Olympia, Business Development and Regulatory Affairs Manager

Fr. Gil Peter Coching, SHIELD Director

Fast Facts

Learn more.....

Basic Information

Nature of Business

License Importer & Distributor of Medical Device
License Importer & Distributor of Drugs
License to handle Dangerous Drugs
License Food Distributor & Wholesaler

CUSTOMERS

Delex will be establishing strong customer relationships with MDs, Intensivists, Hospital Administrators, Medical Directors, Purchasers, Nurses & Pharmacists, and Drugstores owners and staffs

PRODUCT PORTFOLIOS & PARTNERSHIP

  1. Smiths Medical – CADD Legacy (Ambulatory Infusion Pump)
  2. Axton Pharmaceutical of Portugal – Specialty Drugs
  3. ICU Medical Inc., USA – Critical Care Catheters & Non-proprietary IV Sets
  4. Innogene Kalbiotech of Indonesia – Totilac (Hypertonic Sodium Lactate)
  5. Claris Lifesciences – Bacimycin (Clindamycin) and Spectrax (Cefepime)
  6. Kemex Laboratories of Argentina – Specialty Drugs
  7. MD Pharma, Philippines –  Endurpin (Nalbuphine HCl) and Midazolex (Midazolam)
  8. Sandoz Philippines – Fendermal (Fentanyl patch)
  9. United Biotech of India – Critical Care Drugs and Other Specialty Drugs
  10. Ambica Philippines – Ifimol (Paracetamol I.V)
  11. JM Tolmann – Protorvas (Atorvastatin), Proflow (Clopidogrel), and Pronafil (Sildenafil)

Lot 4 Blk 4 Carnation Street Corner Magnolia Street Barangay Sauyo Novaliches Quezon City Philippines.

Trunk Lines # 024260270 / 024260271
Fax # 6969835 /4553892
Globe # 09178703384/09175468547
Smart # 09989876472
Sun # 09257107617
Mon. – Fri., 8 AM – 5 PM
Closed Saturday and Sunday